Founders’ Corner – Berry Consultants

News & Announcements

Berry Consultants Transitioning from I-SPY Trials

August 4, 2022

FDA Approves Dabrafenib Plus Trametinib for BRAF V600E–Mutated Unresectable or Metastatic Solid Tumors

June 22, 2022

Berry Consultants Acquires ADDPLAN® Clinical Trial Simulation Software from ICON

March 1, 2022

EU-PEARL Webinar – Non-Concurrent Controls in Platform Trials

Dr. Scott Berry and Dr. Kert Viele of Berry Consultants presented in the EU-PEARL webinar on February 24.

February 24, 2022

A Faster Way to Find Good Medical Treatments Is Gaining Ground

January 19, 2022

Immunicom Conference Highlights Innovation in Clinical Trial Design to Advance its Breakthrough Cancer Immunotherapy Platform

November 2, 2021

DIA BSWG KOL Lecture Series: Bayesian Shared Parameter Analysis of Mortality and Function within an Adaptive Platform Trial for ALS

October 14, 2021

Los Angeles County Predictive Modeling of the COVID-19 Pandemic

Berry Consultants released a video highlighting the efforts of the LA County Predictive Modeling for the COVID-19 Pandemic, an effort which Berry Consultants supported from

September 10, 2021

Global Coalition for Adaptive Research releases a series of videos spotlighting Don Berry, Founder of Berry Consultants, and the GBM Agile trial

September 3, 2021

Podcast: Bayesian Analysis, Using Prior Information to Interpret the Results of Clinical Trials from

September 2, 2021

Made with ❤ by Austin Web Design